[ESPR] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
03-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -23.99%
YoY- -35.94%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -43,337 -40,541 -28,956 -17,402 -14,035 -14,585 -13,122 121.93%
Tax 433 482 423 488 494 457 287 31.57%
NP -43,337 -40,541 -28,956 -17,402 -14,035 -14,585 -13,122 121.93%
Tax Rate - - - - - - - -
Total Cost 43,337 40,541 28,956 17,402 14,035 14,585 13,122 121.93%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -1.92 -1.80 -1.28 -0.77 -0.62 -0.65 -0.58 122.27%
EPS Diluted -1.92 -1.80 -1.28 -0.77 -0.62 -0.65 -0.58 122.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.